Volume 10,Issue 3
LifeTrain: Driving lifelong learning for biomedical pro fessionals
This article describes LifeTrain — the European common framework for continuing professional development in the biomedical sciences. An important goal of LifeTrain is to support biomedical professionals to work collaboratively across disciplines, sectors and national boundaries. LifeTrain is an open community with a unifying goal; it brings together many excellent, but disparate, activities into a process towards establishing a focused and coherent framework for continuing professional development in the biomedical sciences. This collaborative approach provides the critical mass to make a major contribution to strengthen the skills and competencies of biomedical professionals in a rapidly changing environment. LifeTrain's signatories, which include multinational pharmaceutical companies, research infrastructures, professional and scientific bodies, higher-education institutes and research institutes, have agreed to the principles of the framework and to continue to collaborate to implement LifeTrain. We warmly invite others to join us.
1. Silva H, Stonier P, Buhler F R, et al. 2013, Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology, vol.4: 105. http://dx.doi.org/10.3389/fphar.2013.00105
2. Muindi F and Keller JB, 2015, Emerging network of resources for exploring paths beyond academia. Nature Biotechnology, vol.33: 775–778. http://dx.doi.org/10.1038/nbt.3282
3. Christensen C M, 1997, The innovator's dilemma: When new technologies cause great firms to fail. Boston, Massachusetts, USA: Harvard Business School Press.
4. The Innovative Medicines Initiative (IMI) Scientific Research Agenda: Revision 2011, n.d., viewed September 25, 2015, <http://www.imi.europa.eu/content/research-agenda>
5. What are RIs? European Commission Research and Innovation, n.d., viewed September 18, 2015, <http://ec.europa.eu/research/infrastructures/index_en.cfm?pg=what>
6. European Federation of Pharmaceutical Industries and Associations (EFPIA) home page, n.d., viewed September 20, 2015, <http://www.efpia.eu/>
7. Projects: Ongoing projects, Innovative Medicines Initiative (IMI), n.d., viewed September 25, 2015, <http://www.imi.europa.eu/content/ongoing-projects>
8. Position paper on Horizon 2020: ESFRI Biological and Medical Research Infrastructures, 2013, viewed September 25, 2015, <www.infrafrontier.eu/sites/infrafrontier.eu/files/upload/public/pdf/BMS_RI_PositionHorizon2012.pdf>
9. Green paper on The European Research Area (ERA): New perspectives [COM(2007) 161], viewed September 17, 2015, <http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52007DC0161>
10. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions [COM(2010) 546], viewed September 25, 2015, <http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM:2010:0546:FIN>
11. Hardman M, Brooksbank C, Johnson C, et al. 2013, LifeTrain: Towards a European framework for continuing professional development in biomedical sciences. Nature Reviews Drug Discovery, vol.12: 407–408. http://dx.doi.org/10.1038/nrd4026
12. LifeTrain, n.d., viewed November 11, 2015, <www.lifetrain.eu>
13. How important is CPD? Professional Associations Research Network, n.d., viewed September 20, 2015, <http://www.parnglobal.com/about-our-research/continuing-professional-development>
14. Davis NL and Willis CE, 2004, A new metric for continuing medical education credit. Journal of Continuing Education in the Health Professions, vol.24(3): 139–144. http://dx.doi.org/10.1002/chp.1340240304
15. Campbell C, Silver I, Sherbino I, et al. 2010, Competency-based continuing professional development. Medical Teacher, vol.32(8): 657–662. http://dx.doi.org/10.3109/0142159X.2010.500708
16. Cedefop, 2009, European guidelines for validating non-formal and informal learning. Luxembourg: Office for Official Publications of the European Communities.
17. Payton A, Janko C, Renn O, et al. 2013, On-course® portal: A tool for in-service training and career development for biomedical scientists. Drug Discovery Today, vol.18(17–18): 803–806. http://dx.doi.org/10.1016/j.drudis.2013.04.004
18. Klech H, Brooksbank C, Price S, et al. 2012, European initiative towards quality standards in education and training for discovery, development and use of medicines. European Journal of Pharmaceutical Sciences, vol.45(5): 515–520. http://dx.doi.org/10.1016/j.ejps.2011.12.005
19. Nurse P, Sunami A, Polka J, et al. 2015, STEM education: To build a scientist. Nature, vol.523: 371–373. http://dx.doi.org/10.1038/nj7560-371a
20. Welch L, Lewitter F, Schwartz R, et al. 2014, Bioinformatics curriculum guidelines: Toward a definition of core competencies. PLoS Computational Biology, vol.10: e1003496. http://dx.doi.org/10.1371/journal.pcbi.1003496
21. Ellard S, Thornton J, Aitman T, Boustred C, Brooksbank C, et al. 2015, Developing Clinical Bioinformatics Training in the NHS — a Timeline for Action. UK: Health Education England.
22. Griesbacher T and Drago F, 2014, European Certified Pharmacologists (EuCP): Standards for postgraduate professional training in pharmacology established by EPHAR, the Federation of European Pharmacological Societies. Intrinsic Activity, vol.2(Suppl. 1): A3.1.
23. Imi-train: Education and training in the medical, biomedical and pharmaceutical sciences, n.d., viewed September 25, 2015, <http://www.imi-train.eu>
24. EMBL Conference series, n.d., viewed September 25, 2015, <http://www.embl.de/training/events/2016/LLL16-01/index.html>
25. The Innovative Medicines Initiative (IMI), n.d., viewed September 25, 2015, <http://www.imi.europa.eu>